Cancer News and Research

Latest Cancer News and Research

ChemoCentryx commences CCX832 Phase I trial in patients with psoriasis

ChemoCentryx, today announced the initiation of a Phase I clinical trial of CCX832, an orally-administered small molecule that is a potent and selective inhibitor of the chemoattractant receptor, ChemR23.

26 Jan 2011

ECCA and EDMA advance the EU health literacy debate

As part of the 2011 European Cervical Cancer Week, EDMA, the European Diagnostic Manufacturers Association and the ECCA, the European Cervical Cancer Association jointly organised the "Better Health Literacy for Better Health in Europe" dinner debate.

26 Jan 2011

ASTRO reaffirms commitment to quality, issues progress report on patient safety plan

The American Society for Radiation Oncology is continuing its commitment to Target Safely, a six-point patient protection plan developed in January 2010, to improve the safety and quality of radiation therapy treatments and reduce the chances of medical errors.

26 Jan 2011

Faked cancer lands British man in jail

A British father who faked a terminal cancer to his family and friends to ‘con’ them out of cash, is beginning a 20 month jail sentence today. Simon Swift, 39, from Rugby in Warwickshire, central England started by telling his wife and three teenage children that he only had months to live and sold tickets worth hundreds of pounds for a fake charity auction. He claimed in May that the cancer had started in his spine and had become terminal. He even shaved his hair and claimed marks on his neck were from radiotherapy.

26 Jan 2011

Traffic noise and stroke risk: Study

A new study shows that traffic noise may increase the risk of stroke, particularly for older individuals. The study looked at the association between road traffic noise and stroke in more than 51,000 Danish people and found that for every 10-decibel increase in noise level, the risk of stroke increased by 14 percent. In those over 65, the risk of stroke increased 27 percent.

26 Jan 2011

Survival following transplant surgery for liver cancer not impacted by HIV-positive status

French researchers determined that infection with human immunodeficiency virus (HIV) impaired results of transplant surgery for liver cancer, with more HIV infected patients dropping off the transplantation wait list. The team found that overall survival and recurrence-free survival was not impacted following liver transplantation in patients with controlled HIV disease.

25 Jan 2011

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.

25 Jan 2011

FDA grants BioSante Orphan Drug designation for Melanoma Cancer Vaccine

BioSante Pharmaceuticals, Inc. today announced the receipt of Orphan Drug designation for its Melanoma Cancer Vaccine in the treatment of stage IIb to IV melanoma, from the FDA's Office of Orphan Products Development. Melanoma is the most deadly form of skin cancer.

25 Jan 2011

Emergent BioSolutions initiates TRU-016 Phase Ib/II study for chronic lymphocytic leukemia

Emergent BioSolutions Inc. today announced the initiation of a Phase Ib/II study (16201) of TRU-016 for chronic lymphocytic leukemia (CLL). TRU-016 is a CD37-directed Small Modular ImmunoPharmaceutical (SMIP™) protein therapeutic in development for the treatment of B-cell malignancies. TRU-016 is being developed in collaboration with Abbott.

25 Jan 2011

Realignment with participants' interest important for future of genomic research

Obtaining consent for genetic studies can be an opportunity for researchers to foster respectful engagement with participants, not merely to mitigate legal risk. This shift is proposed in a policy forum appearing tomorrow, Jan. 21, in Science, the journal of the American Academy for the Advancement of Science.

25 Jan 2011

Massive drinks mean massive calories

When you're ordering the new Starbucks "trenta" you're not only getting a massive drink (31 ounces) but massive calories (up to 600) - with the potential to pack on more than 60 extra pounds in one year.

25 Jan 2011

NINDS awards AndroScience $3.8M cooperative translational research grant for Kennedy's Disease

AndroScience Corp., based in San Diego, California, announced receiving a $3.8 Million, 3-year milestone-driven, cooperative translational research grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH).

25 Jan 2011

P.I.C., Pink Ladies raise funds for Breast Cancer Care

Steve Rigby, Senior Area Manager for P.I.C. in Abu Dhabi said, "We are delighted to have helped raise funds for Breast Cancer Care. It's been a pleasure working with the Pink Ladies and we look forward to working on future events together."

25 Jan 2011

Northwest Biotherapeutics resumes enrollment in DCVax Phase II brain cancer clinical trial

Cutting edge, patient-specific vaccine treatments like DCVax® provide for a longer life expectancy along with a better quality of life for brain cancer patients, an improvement over current conventional brain tumor treatments. "The vaccine that I received has extended the median survival of Grade IV brain cancer (GBM) from 14.6 months, with conventional treatment, to over 36 months," stated Bob Gibbs, a 7 year brain cancer survivor, who has defied the odds statistically, thanks to the experimental brain cancer vaccine DCVax®.

25 Jan 2011

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Genomic Health, Inc. today announced presentation of three studies at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium, including one finding that high tumor grade was not a marker of higher recurrence risk in stage II colon cancer, suggesting that other markers, such as the Oncotype DX® Recurrence Score® (RS) test as well as T-stage and mismatch repair (MMR) status, should be considered by physicians during the treatment decision-making process.

25 Jan 2011

Taiwanese research team develops large-scale proactive cancer treatment system first-generation prototype

A Taiwanese research team, led by Prof. Ming-Shing Young of Department of Electrical Engineering at National Cheng Kung University (NCKU), has successfully developed a large-scale proactive cancer treatment system first-generation prototype which includes Frequency-Adjustable High Frequency Induction Heating Machine (HFIHM) and 3D Magnetically Guiding Endoscope System (3DMGES).

25 Jan 2011

Regulatory changes needed to protect public health from exposure to toxicants

Americans are exposed to hundreds, if not thousands, of suspected toxic substances every day, substances that affect the development and function of the brain, immune system, reproductive organs or hormones. Children are the most vulnerable. But no public health law requires product testing of most chemical compounds before they enter the marketplace.

25 Jan 2011

ASCO urges physicians, medical schools to improve quality of life for people with cancer

The American Society of Clinical Oncology today called on physicians, medical schools, insurers, and others to help improve quality of life for people with advanced cancer.

25 Jan 2011

Diamyd Medical reports first quarter group total net sales of MSEK 144.5

Diamyd completed screening for US Phase III study in type 1 diabetes. The screening of patients for the US Phase III study, DiaPrevent, was completed, ending the recruitment campaign. More than 310 recently diagnosed type 1 diabetes patients between 10 and 20 years of age had, at the completion of screening, been enrolled in the study and received their first injection of the antigen-based therapy Diamyd® or placebo.

25 Jan 2011

ASU Biodesign Institute hosts international research consortium on early detection of lung cancer

To address the latest issues on the early detection of lung cancer, the Biodesign Institute at Arizona State University will host an international research consortium in Scottsdale, Ariz., Feb. 25-26.

25 Jan 2011

Cancer News and Research

Latest Cancer News and Research

ChemoCentryx commences CCX832 Phase I trial in patients with psoriasis

ECCA and EDMA advance the EU health literacy debate

ASTRO reaffirms commitment to quality, issues progress report on patient safety plan

Faked cancer lands British man in jail

Traffic noise and stroke risk: Study

Survival following transplant surgery for liver cancer not impacted by HIV-positive status

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

FDA grants BioSante Orphan Drug designation for Melanoma Cancer Vaccine

Emergent BioSolutions initiates TRU-016 Phase Ib/II study for chronic lymphocytic leukemia

Realignment with participants' interest important for future of genomic research

Massive drinks mean massive calories

NINDS awards AndroScience $3.8M cooperative translational research grant for Kennedy's Disease

P.I.C., Pink Ladies raise funds for Breast Cancer Care

Northwest Biotherapeutics resumes enrollment in DCVax Phase II brain cancer clinical trial

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Taiwanese research team develops large-scale proactive cancer treatment system first-generation prototype

Regulatory changes needed to protect public health from exposure to toxicants

ASCO urges physicians, medical schools to improve quality of life for people with cancer

Diamyd Medical reports first quarter group total net sales of MSEK 144.5

ASU Biodesign Institute hosts international research consortium on early detection of lung cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in